SLRX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Salarius Pharmaceuticals Inc (SLRX).


$2.65M Market Cap.

As of 03/21/2025 5:00 PM ET (MRY) • Disclaimer

SLRX Market Cap. (MRY)


SLRX Shares Outstanding (MRY)


SLRX Assets (MRY)


Total Assets

$3.02M

Total Liabilities

$1.51M

Total Investments

$0

SLRX Income (MRY)


Revenue

$0

Net Income

-$5.58M

Operating Expense

$5.73M

SLRX Cash Flow (MRY)


CF Operations

-$4.53M

CF Investing

$0

CF Financing

$1.06M

SLRX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SLRX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$3,022,974 (-54.10%)

$6,586,523 (-55.04%)

$14,650,799 (-64.12%)

$40,833,868 (63.78%)

Assets Current

$2,987,562 (-54.18%)

$6,519,673 (-55.10%)

$14,520,298 (-51.86%)

$30,163,595 (90.95%)

Assets Non-Current

$35,412 (-47.03%)

$66,850 (-48.77%)

$130,501 (-98.78%)

$10,670,273 (16.80%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$8,865,909 (0.00%)

Shareholders Equity

$1,511,695 (-71.41%)

$5,287,282 (-49.09%)

$10,384,608 (-73.18%)

$38,722,985 (74.75%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$2,434,528 (-58.74%)

$5,899,910 (-51.27%)

$12,106,435 (-58.56%)

$29,214,380 (162.75%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$1,610,490 (0.00%)

$1,610,490 (-58.23%)

Trade & Non-Trade Payables

$936,994 (55.43%)

$602,853 (-78.91%)

$2,858,330 (85.23%)

$1,543,096 (-16.76%)

Accumulated Retained Earnings (Deficit)

-$81,923,618 (-7.30%)

-$76,347,841 (-19.66%)

-$63,805,148 (-98.17%)

-$32,197,192 (-65.72%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$221,866 (-23.40%)

$289,643 (0%)

$0 (0%)

$0 (0%)

Debt Current

$221,866 (-23.40%)

$289,643 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$1,511,279 (16.32%)

$1,299,241 (-69.55%)

$4,266,191 (102.10%)

$2,110,883 (-23.88%)

Liabilities Current

$1,511,279 (16.32%)

$1,299,241 (-69.55%)

$4,266,191 (102.10%)

$2,110,883 (-23.88%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

SLRX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$1,840,216 (-64.84%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$4,964,289 (-13.23%)

$5,721,197 (-19.85%)

$7,138,403 (16.93%)

$6,104,627 (-0.02%)

Research & Development Expense

$770,027 (-89.27%)

$7,173,747 (-54.70%)

$15,836,828 (85.26%)

$8,548,520 (23.64%)

Operating Expenses

$5,734,316 (-55.53%)

$12,894,944 (-59.50%)

$31,841,140 (117.30%)

$14,653,147 (12.55%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$5,575,777 (55.55%)

-$12,542,693 (60.32%)

-$31,607,956 (-147.55%)

-$12,768,238 (-73.66%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$5,575,777 (55.55%)

-$12,542,693 (60.32%)

-$31,607,956 (-147.55%)

-$12,768,238 (-73.66%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$5,575,777 (55.55%)

-$12,542,693 (60.32%)

-$31,607,956 (-147.55%)

-$12,768,238 (-64.78%)

Weighted Average Shares

$962,210 (-70.53%)

$3,264,620 (53.66%)

$2,124,511 (28.40%)

$1,654,638 (165.53%)

Weighted Average Shares Diluted

$962,210 (-70.53%)

$3,264,620 (53.66%)

$2,124,511 (28.40%)

$1,654,638 (165.53%)

Earning Before Interest & Taxes (EBIT)

-$5,575,777 (55.55%)

-$12,542,693 (60.32%)

-$31,607,956 (-147.55%)

-$12,768,238 (-73.66%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$1,840,216 (-64.84%)

Operating Income

-$5,734,316 (55.53%)

-$12,894,944 (59.50%)

-$31,841,140 (-148.51%)

-$12,812,931 (-64.56%)

SLRX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

-$1,500,000 (0%)

$0 (0%)

Net Cash Flow from Financing

$1,059,955 (-84.04%)

$6,639,612 (234.09%)

$1,987,376 (-92.98%)

$28,295,963 (59.92%)

Net Cash Flow from Operations

-$4,525,337 (64.77%)

-$12,846,137 (26.99%)

-$17,595,321 (-72.50%)

-$10,200,197 (1.08%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,465,382 (44.17%)

-$6,206,525 (63.72%)

-$17,107,945 (-194.54%)

$18,095,766 (145.21%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$1,500,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

-$466,505 (-66.07%)

-$280,917 (0%)

$0 (0%)

-$477,028 (51.05%)

Issuance (Purchase) of Equity Shares

$1,526,460 (-77.94%)

$6,920,529 (248.22%)

$1,987,376 (-93.09%)

$28,772,991 (94.43%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$273,730 (-47.84%)

$524,838 (-34.13%)

$796,803 (42.53%)

$559,044 (75.03%)

Depreciation Amortization & Accretion

$4,424 (-55.98%)

$10,051 (50.53%)

$6,677 (-65.19%)

$19,183 (6.23%)

SLRX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

100.00% (0.00%)

Profit Margin

-

-

-

-693.80% (-368.47%)

EBITDA Margin

-

-

-

-692.80% (-394.50%)

Return on Average Equity (ROAE)

-213.20% (-7.68%)

-198.00% (-42.96%)

-138.50% (-377.59%)

-29.00% (27.32%)

Return on Average Assets (ROAA)

-145.60% (-7.69%)

-135.20% (-10.73%)

-122.10% (-337.63%)

-27.90% (22.07%)

Return on Sales (ROS)

-

-

-

-693.80% (-393.81%)

Return on Invested Capital (ROIC)

997.50% (63.10%)

611.60% (-89.35%)

5741.20% (1215.23%)

-514.80% (-6.85%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.32 (-88.17%)

-0.17 (-64.08%)

-0.1 (93.58%)

-1.6 (11.81%)

Price to Sales Ratio (P/S)

-

-

-

11.14 (311.26%)

Price to Book Ratio (P/B)

1.75 (262.40%)

0.48 (44.05%)

0.34 (-41.97%)

0.58 (-28.96%)

Debt to Equity Ratio (D/E)

1 (306.50%)

0.25 (-40.15%)

0.41 (647.27%)

0.06 (-56.00%)

Earnings Per Share (EPS)

-5.79 (-50.78%)

-3.84 (74.19%)

-14.88 (-92.75%)

-7.72 (38.24%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

1.11 (-86.76%)

Free Cash Flow Per Share (FCFPS)

-4.7 (-19.52%)

-3.94 (52.49%)

-8.28 (-34.34%)

-6.17 (62.75%)

Book Value Per Share (BVPS)

1.57 (-3.02%)

1.62 (-66.86%)

4.89 (-79.11%)

23.4 (-34.19%)

Tangible Assets Book Value Per Share (TABVPS)

3.14 (55.70%)

2.02 (-70.74%)

6.9 (-64.31%)

19.32 (-25.07%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

1 (200.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.05 (-85.16%)

0.36 (-13.74%)

0.42 (-43.36%)

0.74 (158.99%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0.04 (-83.47%)

Current Ratio

1.98 (-60.60%)

5.02 (47.41%)

3.4 (-76.18%)

14.29 (150.88%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$4,525,337 (64.77%)

-$12,846,137 (26.99%)

-$17,595,321 (-72.50%)

-$10,200,197 (1.10%)

Enterprise Value (EV)

-$303,451 (93.35%)

-$4,561,516 (65.79%)

-$13,334,533 (-40.37%)

-$9,499,566 (-202.57%)

Earnings Before Tax (EBT)

-$5,575,777 (55.55%)

-$12,542,693 (60.32%)

-$31,607,956 (-147.55%)

-$12,768,238 (-73.66%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$5,571,353 (55.55%)

-$12,532,642 (60.34%)

-$31,601,279 (-147.87%)

-$12,749,055 (-73.83%)

Invested Capital

-$700,967 (-117.03%)

-$322,985 (81.24%)

-$1,721,827 (-367.91%)

$642,696 (-75.76%)

Working Capital

$1,476,283 (-71.72%)

$5,220,432 (-49.09%)

$10,254,107 (-63.45%)

$28,052,712 (115.40%)

Tangible Asset Value

$3,022,974 (-54.10%)

$6,586,523 (-55.04%)

$14,650,799 (-54.17%)

$31,967,959 (98.97%)

Market Capitalization

$2,651,729 (3.58%)

$2,559,981 (-26.56%)

$3,485,687 (-84.44%)

$22,404,161 (24.07%)

Average Equity

$2,615,292 (-58.72%)

$6,335,912 (-72.24%)

$22,824,209 (-48.13%)

$44,000,718 (126.74%)

Average Assets

$3,829,905 (-58.71%)

$9,275,302 (-64.17%)

$25,883,918 (-43.51%)

$45,817,290 (111.57%)

Invested Capital Average

-$558,962 (72.74%)

-$2,050,810 (-272.50%)

-$550,549 (-122.20%)

$2,480,212 (62.54%)

Shares

1,441,157 (-63.41%)

3,938,433 (72.87%)

2,278,227 (25.99%)

1,808,245 (127.81%)